[go: up one dir, main page]

NO903291L - Renin-hemmende aminooligohydroksyderivater. - Google Patents

Renin-hemmende aminooligohydroksyderivater.

Info

Publication number
NO903291L
NO903291L NO90903291A NO903291A NO903291L NO 903291 L NO903291 L NO 903291L NO 90903291 A NO90903291 A NO 90903291A NO 903291 A NO903291 A NO 903291A NO 903291 L NO903291 L NO 903291L
Authority
NO
Norway
Prior art keywords
aminooligo
hydroxyde
inhibitive
derivatives
pure
Prior art date
Application number
NO90903291A
Other languages
English (en)
Other versions
NO903291D0 (no
Inventor
Heinz-Werner Kleemann
Hansjoerg Urbach
Adalbert Wagner
Dieter Ruppert
Wolfgang Linz
Werner Kramer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3924506A external-priority patent/DE3924506A1/de
Priority claimed from DE19893932817 external-priority patent/DE3932817A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO903291D0 publication Critical patent/NO903291D0/no
Publication of NO903291L publication Critical patent/NO903291L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
  • Solid Fuels And Fuel-Associated Substances (AREA)

Abstract

Forbindelser med formel I. der. A, R • R, Rog n er definert som angitt 1 beskrivelsen, fremgangsmåte for fremstilling derav, anvendelse som legemiddel og farmasøytisk middel inneholdende disse er beskrevet.
NO90903291A 1989-07-25 1990-07-24 Renin-hemmende aminooligohydroksyderivater. NO903291L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3924506A DE3924506A1 (de) 1989-07-25 1989-07-25 Renin-hemmende aminooligohydroxy-derivate
DE19893932817 DE3932817A1 (de) 1989-09-30 1989-09-30 Renin-hemmende aminooligohydroxy-derivate

Publications (2)

Publication Number Publication Date
NO903291D0 NO903291D0 (no) 1990-07-24
NO903291L true NO903291L (no) 1991-01-28

Family

ID=25883333

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903291A NO903291L (no) 1989-07-25 1990-07-24 Renin-hemmende aminooligohydroksyderivater.

Country Status (20)

Country Link
EP (1) EP0410278B1 (no)
JP (1) JPH0366652A (no)
KR (1) KR910002776A (no)
CN (1) CN1049164A (no)
AT (1) ATE100463T1 (no)
AU (1) AU639246B2 (no)
CA (1) CA2021822A1 (no)
CS (1) CS368890A3 (no)
DE (1) DE59004292D1 (no)
DK (1) DK0410278T3 (no)
ES (1) ES2062214T3 (no)
FI (1) FI903701A7 (no)
HU (1) HU205140B (no)
IE (1) IE902686A1 (no)
IL (1) IL95166A0 (no)
MA (1) MA21913A1 (no)
NO (1) NO903291L (no)
NZ (1) NZ234608A (no)
PL (1) PL286188A1 (no)
PT (1) PT94798A (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW209870B (no) * 1990-01-18 1993-07-21 Pfizer
IE68045B1 (en) * 1990-05-11 1996-05-15 Abbott Lab Renin inhibitors
JPH06500561A (ja) * 1990-08-24 1994-01-20 ジ・アップジョン・カンパニー 遷移状態模擬体としてのアミノポリオール含有ペプチド
EP0483403A1 (en) * 1990-10-31 1992-05-06 Hoechst Aktiengesellschaft Derivatives of amino acids as inhibitors of renin, methods for their preparation, medicaments containing them and their use
US6900020B2 (en) * 2000-04-10 2005-05-31 Yuichi Ishida Hypotensors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK34086A (da) * 1985-01-23 1986-07-24 Abbott Lab Peptidylaminodioler
NZ218937A (en) * 1986-01-16 1990-03-27 Abbott Lab Functionalised peptidyl aminodiols and -triols as renin inhibitors and pharmaceutical compositions
US4863905A (en) * 1987-02-04 1989-09-05 Warner-Lambert Company Renin inhibitors II

Also Published As

Publication number Publication date
CS368890A3 (en) 1992-02-19
IL95166A0 (en) 1991-06-10
ATE100463T1 (de) 1994-02-15
AU639246B2 (en) 1993-07-22
PT94798A (pt) 1991-03-20
EP0410278B1 (de) 1994-01-19
FI903701A7 (fi) 1991-01-26
HU904582D0 (en) 1990-12-28
NO903291D0 (no) 1990-07-24
HU205140B (en) 1992-03-30
ES2062214T3 (es) 1994-12-16
PL286188A1 (en) 1991-04-22
KR910002776A (ko) 1991-02-26
CN1049164A (zh) 1991-02-13
MA21913A1 (fr) 1991-04-01
IE902686A1 (en) 1991-02-27
NZ234608A (en) 1991-12-23
EP0410278A1 (de) 1991-01-30
CA2021822A1 (en) 1991-01-26
JPH0366652A (ja) 1991-03-22
DK0410278T3 (da) 1994-05-24
AU5971990A (en) 1991-01-31
DE59004292D1 (de) 1994-03-03
HUT55033A (en) 1991-04-29
FI903701A0 (fi) 1990-07-23

Similar Documents

Publication Publication Date Title
SE9904505D0 (sv) Novel compounds
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
FI903215A7 (fi) Heteroaryyliamino- ja heteroaryylioksipyridiiniamiineja ja niihin liittyviä yhdisteitä, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkkeinä
DK0506539T3 (da) heterocykliske alkylamider, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
HU903094D0 (en) Process for the preparation of antiphlogistic amino-phenol derivatives
EG19361A (en) A process for the preparation of piperidine compound having local anaesthetica and analgetic
ZA953701B (en) New atagonist compounds
NO178768C (no) 11-aryl-4-östrener og antikonsepsjonsmidler inneholdende disse
WO1990009993A3 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
FI934298A0 (fi) Kristallin tiagabine-hydrokloridmonohydrat, dess framstaellning och dess anvaendning
PT722319E (pt) Derivados de antraciclinona e a sua utilizacao no tratamento da amiloidose
DK0486386T3 (da) Hidtil ukendte N-benzoylprolinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES2020171T3 (es) Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos.
SE9400447D0 (sv) New compounds
MY114282A (en) Anthracycline derivatives
NO903291L (no) Renin-hemmende aminooligohydroksyderivater.
FI905191A7 (fi) Bensocykloalylaminopyridinaminer och motsvarande föreningar, förfarande och mellanprodukter för deras framställning och deras användning som läkemedel
ATE200291T1 (de) Cephemderivate
FI940031L (fi) Uusia 2-syaani-3-hydroksipropenamidijohdannaisia, menetelmä niiden valmistamiseksi, niiden käyttö lääkkeinä ja niitä sisältävät farmaseuttiset koostumukset
HUT49876A (en) Process for producing 6-oxopyridazine derivatives and pharmaceutical compositions comprising same
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
DK256689A (da) 1,2-dithiol-3-thion-s-oxid-forbindelser til anven delse som laegemidler